Japanese Insurance Stock News

Hakuhodo DY Holdings (TSE:2433) drew investor attention after its board approved the disposal of 275,950 treasury shares as restricted stock compensation for directors and officers at ¥1,222 per share. See our latest analysis for Hakuhodo DY Holdings. The restricted stock plan lands at a time when Hakuhodo DY Holdings' short term momentum has been positive, with a 30 day share price return of 12.91% and a 90 day share price return of 16.38%. However, the 5 year total shareholder return is...

Cyberattack recovery and bond shelf filing put Nichirei in focus Nichirei (TSE:2871) is back on investor radars after a cyberattack disrupted its temperature controlled logistics and frozen food operations, followed by an announcement of resumed shipping and a ¥50 billion bond shelf registration. See our latest analysis for Nichirei. The cyberattack and bond shelf filing come against a backdrop of firm share price momentum, with Nichirei’s 90 day share price return of 10.96% and 1 year total...

KDX Realty Investment (TSE:8972) is in focus after its asset manager, Kenedix Real Estate Fund Management Inc., moved to launch KDX Kolet REIT Inc., a new J-REIT focused on single family rental properties. See our latest analysis for KDX Realty Investment. The latest news around KDX Realty Investment comes as its share price trades at ¥157,200, with a 1 day share price return of 1.42% and a year to date decline of 10.43%, while the 1 year total shareholder return of 4.60% points to income...

Board decision on unit split and governance changes Daiwa Office Investment (TSE:8976) has approved an investment unit split, along with amendments to its Articles of Incorporation, aiming to widen investor access and support liquidity in its real estate investment units. See our latest analysis for Daiwa Office Investment. At a share price of ¥330,000, Daiwa Office Investment has seen a 3.61% 1 month share price return, while year to date the share price is down 12.23%, set against a 1 year...

Takeda Pharmaceutical (TSE:4502) is back in focus after releasing new Phase 3 data for its oral TYK2 inhibitor zasocitinib in moderate to severe plaque psoriasis, alongside plans for a US FDA filing. See our latest analysis for Takeda Pharmaceutical. The zasocitinib update comes after a solid run in Takeda Pharmaceutical’s shares, with a 1-month share price return of 10.98% and year to date share price return of 11.47%. The 1-year total shareholder return of 31.40% and 5-year total...

Aeon (TSE:8267) drew fresh attention after its Q1 2027 results on 10 July 2026, as the retailer reported higher sales and revenue year on year and moved from a net loss to profit. See our latest analysis for Aeon. Aeon’s latest Q1 2027 earnings have come after a tough stretch for shareholders, with the share price down 43.86% year to date but still posting a 3 year total shareholder return of 47.26%. This suggests long term holders have seen a very different experience to recent buyers. If...

Nuclear energy stocks are back in focus as investors look for power sources that are both reliable and less exposed to the swings in fossil fuel markets, especially with energy prices and inflation closely watched across regions. The Nuclear Energy Stocks screener helps you quickly filter companies involved in uranium production, enrichment and reactor operations so you can focus on businesses tied directly to long term electricity demand and energy security themes. In this article, you will...

Mitsui (TSE:8031) has partnered with PureCycle Technologies and RM TOHCELLO to introduce recycled polypropylene BOPP films in Japan. The collaboration uses PureCycle's recycling process to supply high purity recycled resin for BOPP film production. Pilot production has already produced usable results, with commercial agreements targeted by 2027. Mitsui enters this agreement with recycled polypropylene BOPP films as a fresh area of focus, while its share price stands around ¥4,662.0. The...

With bond markets shifting and inflation signals mixed across regions, many investors are looking for ways to keep cash flow steady without guessing where growth will come from next. That is where high quality dividend payers can help. The Dividend Powerhouses screener focuses on companies with more than a 5% yield that is covered by earnings, growing and relatively stable, so you are not just chasing high payouts for the sake of it. In this article, you will see three stocks from that list...

Kao’s cosmetics brand KATE recently launched its “KABUKE: Break Convention” international campaign, which debuted on 8 July 2026 and blends Kabuki-inspired aesthetics with shadow-enhancing makeup and self-expression, with products rolling out from 25 July in select Asian markets. This campaign highlights Kao’s push to build KATE into a more globally resonant brand by using distinct Japanese cultural themes to appeal to international consumers. We’ll now examine how KATE’s Kabuki-inspired...

Market context for Toyota Motor stock Toyota Motor (TSE:7203) is back in focus after a proposed class action lawsuit alleged the company collected user data despite cookie opt outs, adding a legal angle to how investors assess the stock. See our latest analysis for Toyota Motor. The share price at ¥2,899.5 has edged higher over the past week and month, but remains down over the past quarter and year to date. Longer term total shareholder returns over 1, 3 and 5 years are positive, suggesting...

Daito Pharmaceutical Co.,Ltd.'s ( TSE:4577 ) healthy profit numbers didn't contain any surprises for investors. We...

The market seemed underwhelmed by last week's earnings announcement from Village Vanguard CO.,LTD. ( TSE:2769 ) despite...

With global growth, inflation and interest rate expectations constantly in focus, many investors are looking for companies that already have strong balance sheets and a solid track record of using shareholders’ capital efficiently. The Solid Balance Sheet and Fundamentals screener filters for stocks with high return on equity, sound financial footing and resilient past performance, which can help you focus on quality rather than short term noise in rates, energy prices or geopolitics. In this...

Baycurrent (TSE:6532) opened Q1 2027 with revenue of ¥44,576 million and basic EPS of ¥70.99, while the trailing twelve months show revenue of ¥158.6 billion and basic EPS of ¥260.82, with earnings growth of 20.6% over the past year. The company has seen revenue move from ¥123,066 million in the trailing twelve months to Q1 2026 to ¥158,601 million in the latest period, as basic EPS over the same trailing window shifted from ¥215.80 to ¥260.82. This quarter serves as a checkpoint on whether...

Mainichi Comnet Co., Ltd.'s ( TSE:8908 ) recent earnings report didn't offer any surprises, with the shares unchanged...

Tone Co., Ltd.'s ( TSE:5967 ) strong earnings report was rewarded with a positive stock price move. Our analysis found...

Osaka Organic Chemical Industry Ltd.'s ( TSE:4187 ) robust earnings report didn't manage to move the market for its...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

TOCALO Co.,Ltd. ( TSE:3433 ), is not the largest company out there, but it saw significant share price movement during...

Last week's earnings announcement from Maruhachi Warehouse Company, Limited ( TSE:9313 ) was disappointing to...

While Union Tool Co. ( TSE:6278 ) might not have the largest market cap around , it saw a decent share price growth of...

As you might know, Toho Co., Ltd. ( TSE:9602 ) last week released its latest first-quarter, and things did not turn out...

Shionogi recently announced that the U.S. FDA has accepted a Supplemental New Drug Application for Fetroja (cefiderocol) to treat pediatric patients with hospital-acquired and ventilator-associated bacterial pneumonia and complicated urinary tract infections caused by specific Gram-negative organisms, with a PDUFA action date set for February 23, 2027. This regulatory step is important because it targets a clear treatment gap for children facing drug-resistant infections, potentially...